The MRC has funded our team research proposal!
We are thrilled to announce we’ve been awarded a grant, part of the Cancer Research and Global Health Initiative of the Medical Research Council (UK), to study potential drug targets of acral lentiginous melanoma (ALM) in Latin American patients. This proposal is also co-led by Dr David Adams (Sanger Institute, UK) and Dr Patricia Possik (Brazilian National Cancer Institute [INCA], Brazil), with the support of Prof Meenhard Herlyn (Wistar Institute, USA) and Dr. Hector Martinez-Said (Mexican National Cancer Institute, Mexico). This award will fund our research into animal models and potential drug targets of ALM for the next two years, and will officially start our collaborations with INCA. We’re very thankful to the MRC for this funding, and can’t wait to get to work!